Michael Gwarisa New research from Oxford University suggests that ejaculation frequency may play a key role in maintaining sperm quality, with findings showing that prolonged sperm storage in the body can lead to deterioration over time. The study found that the longer sperm are stored before ejaculation, the lower their quality, a finding that could
Read More
Michael Gwarisa A monthly injectable HIV treatment combining long-acting cabotegravir and rilpivirine has been shown to outperform standard daily oral antiretroviral therapy (ART) among people who struggle to stick to treatment, according to findings from a major randomized clinical trial. The study, published in February 2026 in the New England Journal of Medicine, provides strong
Read More
Within contemporary peptide research, combinations of signal-modulating molecules are increasingly conceptualized as coordinated frameworks rather than isolated agents. Among these, the pairing of CJC-1295, a growth hormone–releasing hormone (GHRH) analog, with Ipamorelin, a ghrelin receptor–selective secretagogue, has drawn sustained theoretical interest. Research indicates that this blend may offer a unique window into pulsatile endocrine signaling,
Read More
Michael Gwarisa Though it has become a popular fashion statement, especially among modern women, performers, and artists, new research shows that dyeing hair in unnatural shades could be a silent cry for help and a sign of underlying mental health struggles. The full study Blue Hair and the Blues: Dying Your Hair Unnatural Colours is
Read More
On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin)Trusted Source for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Addyi was previously approved in 2015 for the treatment of HSDD in premenopausal women. Premenopause or “before” menopause refers to the reproductive time in a cisgender woman’s life when they have regular menstrual cycles.
Read More
While some patients experience adverse drug reactions (ADRs) when taking medicines, others do not, and in some cases, others do not receive therapeutic benefits from treatment regardless of dosage. One reason for this inter-individual variation in response is differences in genes that code for proteins important in drug response. This has given rise to the field
Read More
By Michael Gwarisa A Memorandum of Understanding (MoU) signed between the Ministry of Health and Child Care (MoHCC) and the China National Institute of Parasitic Diseases (NIPD), will see Zimbabwe becoming a manufacturing powerhouse for Praziquantel, a drug used to treat Schistosomiasis, also known as snail fever or bilharzia. This comes after Zimbabwe was selected to
Read More
FOR the first time, Gogo Mhlanga (75) of Filabusi in Matebeleland South is seeing the Zimbabwe Population Based HIV Impact Assessment (ZIMPHIA 2020) survey banner. She wonders what it is all about and why it has been erected close to her homestead. By Michael Gwarisa A few minutes later, the ZIMPHIA 2020 Southern Region Survey Coordinator, Mrs
Read More